CD73 maintains cancer stem cell properties via AKT-mediated mechanisms, which reduce SOX9 degradation by inhibiting glycogen synthase kinase 3β and enhance its transcription via c-Myc [142]. The gene discussed is NT5E; the disease is cancer.